{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:46:02Z","timestamp":1785804362824,"version":"3.56.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1124\/mol.110.069336","type":"journal-article","created":{"date-parts":[[2010,11,19]],"date-time":"2010-11-19T05:39:29Z","timestamp":1290145169000},"page":"472-478","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["The Novel UDP Glycosyltransferase 3A2: Cloning, Catalytic Properties, and Tissue Distribution"],"prefix":"10.1016","volume":"79","author":[{"given":"Peter I.","family":"MacKenzie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Elliot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuy","family":"Chau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie-Ann","family":"Hulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John O.","family":"Miners","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn","family":"Meech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.110.069336_bib1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.beem.2008.01.001","article-title":"Inactivation of androgens by UDP-glucuronosyltransferases in the human prostate","volume":"22","author":"Barbier","year":"2008","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1124\/mol.110.069336_bib2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1006\/geno.1996.0242","article-title":"The human gene CGT encoding the UDP-galactose ceramide galactosyl transferase (cerebroside synthase): cloning, characterization, and assignment to human chromosome 4, band q26","volume":"34","author":"Bosio","year":"1996","journal-title":"Genomics"},{"key":"10.1124\/mol.110.069336_bib3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jsbmb.2008.03.016","article-title":"Inactivation by UDP-glucuronosyltransferase enzymes: the end of androgen signaling","volume":"109","author":"Chouinard","year":"2008","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1124\/mol.110.069336_bib4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1042\/bj1280215","article-title":"Uridine diphosphate glucuronic acid production and utilization in various tissues actively synthesizing glycosaminoglycans","volume":"128","author":"Gainey","year":"1972","journal-title":"Biochem J"},{"key":"10.1124\/mol.110.069336_bib5","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1006\/bbrc.1998.9646","article-title":"Development of a bicistronic vector driven by the human polypeptide chain elongation factor 1alpha promoter for creation of stable mammalian cell lines that express very high levels of recombinant proteins","volume":"252","author":"Hobbs","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/mol.110.069336_bib6","doi-asserted-by":"crossref","first-page":"33281","DOI":"10.1074\/jbc.M405918200","article-title":"A novel mechanism for the inhibition of hyaluronan biosynthesis by 4-methylumbelliferone","volume":"279","author":"Kakizaki","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.110.069336_bib7","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1124\/dmd.109.028225","article-title":"Influence of N-terminal domain histidine and proline residues on the substrate selectivities of human UDP-glucuronosyltransferase 1A1, 1A6, 1A9, 2B7, and 2B10","volume":"37","author":"Kerdpin","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.110.069336_bib8","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1124\/mol.107.037952","article-title":"Critical roles of residues 36 and 40 in the phenol and tertiary amine aglycone substrate selectivities of UDP-glucuronosyltransferases 1A3 and 1A4","volume":"72","author":"Kubota","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.110.069336_bib9","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/glycob\/9.6.595","article-title":"cDNA cloning and expression of UDP-glucose dehydrogenase from bovine kidney","volume":"9","author":"Lind","year":"1999","journal-title":"Glycobiology"},{"key":"10.1124\/mol.110.069336_bib10","unstructured":"Mackenzie PI (2000) UDP Glucuronosyltransferase: Nomenclature and the Human Genome Project, 10th International Workshop on Glucuronidation and the UDP Glucuronosyltransferases; 22\u201325 April 2001; Hyogo, Japan."},{"key":"10.1124\/mol.110.069336_bib11","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/01.fpc.0000173483.13689.56","article-title":"Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily","volume":"15","author":"Mackenzie","year":"2005","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/mol.110.069336_bib12","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00008571-199708000-00001","article-title":"The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence","volume":"7","author":"Mackenzie","year":"1997","journal-title":"Pharmacogenetics"},{"key":"10.1124\/mol.110.069336_bib13","doi-asserted-by":"crossref","first-page":"36205","DOI":"10.1074\/jbc.M807961200","article-title":"Identification of UDP glycosyltransferase 3A1 as a UDP N-acetylglucosaminyltransferase","volume":"283","author":"Mackenzie","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.110.069336_bib14","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1440-1681.1997.tb02718.x","article-title":"Structure and function of uridine diphosphate glucuronosyltransferases","volume":"24","author":"Meech","year":"1997","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1124\/mol.110.069336_bib15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/03602530903205823","article-title":"UGT3A: novel UDP-glycosyltransferases of the UGT superfamily","volume":"42","author":"Meech","year":"2010","journal-title":"Drug Metab Rev"},{"key":"10.1124\/mol.110.069336_bib16","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0163-7258(91)90065-T","article-title":"Drug glucuronidation in humans","volume":"51","author":"Miners","year":"1991","journal-title":"Pharmacol Ther"},{"key":"10.1124\/mol.110.069336_bib17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/03602530903210716","article-title":"The prediction of drug-glucuronidation parameters in humans: UDP-glucuronosyltransferase enzyme-selective substrate and inhibitor probes for reaction phenotyping and in vitro-in vivo extrapolation of drug clearance and drug-drug interaction potential","volume":"42","author":"Miners","year":"2010","journal-title":"Drug Metab Rev"},{"key":"10.1124\/mol.110.069336_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.pharmtox.44.101802.121546","article-title":"Predicting human drug glucuronidation parameters: application of in vitro and in silico modeling approaches","volume":"44","author":"Miners","year":"2004","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/mol.110.069336_bib19","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1006\/bbrc.1998.8843","article-title":"Characterization of two UDP glucuronosyltransferases that are predominantly expressed in human colon","volume":"247","author":"Mojarrabi","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/mol.110.069336_bib20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1124\/dmd.108.023598","article-title":"Determination of mRNA expression of human UDP-glucuronosyltransferases and application for localization in various human tissues by real-time reverse transcriptase-polymerase chain reaction","volume":"37","author":"Ohno","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.110.069336_bib21","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1242\/jcs.113.2.193","article-title":"Synthesis and sorting of proteoglycans","volume":"113","author":"Prydz","year":"2000","journal-title":"J Cell Sci"},{"key":"10.1124\/mol.110.069336_bib22","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1081\/DMR-100101944","article-title":"Structural and functional studies of UDP-glucuronosyltransferases","volume":"31","author":"Radominska-Pandya","year":"1999","journal-title":"Drug Metab Rev"},{"key":"10.1124\/mol.110.069336_bib23","doi-asserted-by":"crossref","first-page":"31890","DOI":"10.1074\/jbc.M504736200","article-title":"Plasma membrane residence of hyaluronan synthase is coupled to its enzymatic activity","volume":"280","author":"Rilla","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.110.069336_bib24","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/FPC.0b013e3283330767","article-title":"Human UDP-glucuronosyltransferase UGT2A2: cDNA construction, expression, and functional characterization in comparison with UGT2A1 and UGT2A3","volume":"19","author":"Sneitz","year":"2009","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/mol.110.069336_bib25","doi-asserted-by":"crossref","first-page":"25117","DOI":"10.1074\/jbc.273.39.25117","article-title":"Molecular cloning and characterization of the human and mouse UDP-glucose dehydrogenase genes","volume":"273","author":"Spicer","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.110.069336_bib26","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bcp.2003.08.025","article-title":"Evidence that unsaturated fatty acids are potent inhibitors of renal UDP-glucuronosyltransferases (UGT): kinetic studies using human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7","volume":"67","author":"Tsoutsikos","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/mol.110.069336_bib27","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1146\/annurev.pharmtox.40.1.581","article-title":"Human UDP-glucuronosyltransferases: metabolism, expression, and disease","volume":"40","author":"Tukey","year":"2000","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/mol.110.069336_bib28","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1124\/dmd.32.4.413","article-title":"Human udp-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid","volume":"32","author":"Uchaipichat","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.110.069336_bib29","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1097\/FPC.0b013e328256b1b6","article-title":"Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates","volume":"17","author":"Udomuksorn","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/mol.110.069336_bib30","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1158\/0008-5472.CAN-08-3083","article-title":"Androgen-stimulated UDP-glucose dehydrogenase expression limits prostate androgen availability without impacting hyaluronan levels","volume":"69","author":"Wei","year":"2009","journal-title":"Cancer Res"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24029092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24029092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.110.069336","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:50:36Z","timestamp":1739958636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24029092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0026895X24029092"],"URL":"https:\/\/doi.org\/10.1124\/mol.110.069336","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Novel UDP Glycosyltransferase 3A2: Cloning, Catalytic Properties, and Tissue Distribution","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.110.069336","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2011 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}